Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$7.03 -0.13 (-1.82%)
As of 04:00 PM Eastern

ACB vs. CRON, THCX, DHT.UN, GUD, WEED, CPH, SUGR, OGI, FIRE, and EPI

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), DRI Healthcare Trust (DHT.UN), Knight Therapeutics (GUD), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), SugarBud Craft Growers (SUGR), Organigram (OGI), Supreme Cannabis (FIRE), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (TSE:ACB) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, Aurora Cannabis had 3 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for Aurora Cannabis and 0 mentions for Cronos Group. Aurora Cannabis' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company Overall Sentiment
Aurora Cannabis Neutral
Cronos Group Neutral

4.4% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 4.6% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aurora Cannabis presently has a consensus target price of C$8.75, suggesting a potential upside of 24.47%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, research analysts clearly believe Aurora Cannabis is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurora Cannabis has a net margin of -22.55% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -4.40% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
Cronos Group -42.65%-4.40%-3.73%

Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$357.88M1.10-C$44.16M-C$0.33-21.30
Cronos GroupC$130.28M10.58-C$32.78MC$0.0572.00

Aurora Cannabis has a beta of 1.200512, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.208662, meaning that its stock price is 21% more volatile than the S&P 500.

Summary

Cronos Group beats Aurora Cannabis on 8 of the 15 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$395.41MC$1.64BC$5.79BC$9.50B
Dividend YieldN/A2.94%5.63%6.50%
P/E Ratio-21.3068.5876.4825.93
Price / Sales1.101,290.19531.959.59
Price / Cash1.2510.3737.9283.29
Price / Book0.6411.5913.725.62
Net Income-C$44.16MC$20.70BC$3.29BC$301.20M
7 Day Performance3.99%-0.18%1.03%1.24%
1 Month Performance6.84%1.60%6.32%10.33%
1 Year Performance-9.87%4.45%81.16%36.19%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.5419 of 5 stars
C$7.03
-1.8%
C$8.75
+24.5%
-10.1%C$395.41MC$357.88M-21.301,073News Coverage
CRON
Cronos Group
N/AC$3.43
-1.4%
N/A+19.7%C$1.31BC$130.28M68.60450
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
DHT.UN
DRI Healthcare Trust
2.0282 of 5 stars
C$14.73
+1.0%
C$19.50
+32.4%
+21.0%C$817.53MC$139.45M210.43N/ADividend Announcement
GUD
Knight Therapeutics
N/AC$6.45
+0.2%
C$7.15
+10.9%
+1.0%C$642.76MC$384.56M-21.70725
WEED
Canopy Growth
0.3257 of 5 stars
C$1.87
-7.4%
C$1.55
-17.1%
-70.4%C$583.42MC$274.92M-0.452,700Positive News
CPH
Cipher Pharmaceuticals
0.4821 of 5 stars
C$16.79
+4.8%
C$14.75
-12.2%
+6.3%C$426.37MC$47.59M36.505
SUGR
SugarBud Craft Growers
N/AC$13.00
flat
N/A+71.2%C$309.60MC$718.29M22.8044High Trading Volume
OGI
Organigram
2.5525 of 5 stars
C$2.27
-0.4%
C$3.33
+46.5%
+1.6%C$303.92MC$223.82M189.17987
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725

Related Companies and Tools


This page (TSE:ACB) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners